tirzepatide for the treatment of obstructive sleep apnea and obesity Metabolic Therapy OSA: Will Redefine Treatment? The FDA has just approved

People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared to those who use another medication approved specifically for obesity management, a University of British Columbia study suggests

I dont like using these small bottles with pumps

Always inform your prescribing physician about all medications you take

Tirzepatide, the active ingredient in Mounjaro and Zepbound, acts on both the GLP-1 and the GIP receptor

doi: 10.1073/pnas.0810962106 152 WangSMartinsRSullivanMCFriedmanESMisicAMEl-FahmawiAet al

Role of endolysosomes in severe acute respiratory syndrome Coronavirus-2 infection and coronavirus disease 2019 pathogenesis: implications for potential treatments